Marillyn A Hewson Lockheed Martin Corp (LMT) insider trading activity

Marillyn A Hewson is Executive Chairman of LOCKHEED MARTIN CORP. Currently has a direct ownership of 65,447 shares of LMT, which is worth approximately $31.9 Million. The most recent transaction as insider was on Feb 22, 2021, when has been sold 16,184 shares (Common Stock) at a price of $340.47 per share, resulting in proceeds of $5,510,166. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 65.4K

0% 3M change

0% 12M change

Total Value Held $31.9 Million

MARILLYN A HEWSON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 22 2021	SELL Payment of exercise price or tax liability	$5,510,166 $340.47 p/Share	16,184 Reduced 19.83%	65,447 Common Stock
Feb 22 2021	BUY Exercise of conversion of derivative security	-	9,926 Added 10.84%	81,631 Common Stock
Feb 22 2021	BUY Grant, award, or other acquisition	-	31,792 Added 30.72%	71,705 Common Stock
Dec 04 2020	SELL Payment of exercise price or tax liability	$160,209 $366.61 p/Share	437 Reduced 1.09%	39,624 Common Stock
Dec 04 2020	BUY Exercise of conversion of derivative security	-	437 Added 1.08%	40,061 Common Stock
Jan 29 2020	SELL Open market or private sale	$9,598,600 $436.3 p/Share	22,000 Reduced 36.15%	38,863 Common Stock
Jan 26 2020	SELL Payment of exercise price or tax liability	$10,138,665 $432.5 p/Share	23,442 Reduced 27.81%	60,863 Common Stock
Jan 26 2020	BUY Exercise of conversion of derivative security	-	13,396 Added 13.71%	84,305 Common Stock
Jan 26 2020	BUY Grant, award, or other acquisition	$16,988,600 $432.5 p/Share	39,280 Added 35.65%	70,909 Common Stock
Dec 06 2019	SELL Payment of exercise price or tax liability	$223,992 $386.86 p/Share	579 Reduced 1.81%	31,436 Common Stock
Dec 06 2019	BUY Exercise of conversion of derivative security	-	579 Added 1.78%	32,015 Common Stock
Jul 25 2019	SELL Open market or private sale	$7,198,620 $369.16 p/Share	19,500 Reduced 38.42%	31,260 Common Stock
Feb 26 2019	SELL Open market or private sale	$18,250,992 $307.08 p/Share	59,434 Reduced 54.26%	50,096 Common Stock
Feb 26 2019	BUY Exercise of conversion of derivative security	$4,730,946 $79.6 p/Share	59,434 Added 35.18%	109,530 Common Stock
Jan 28 2019	SELL Payment of exercise price or tax liability	$6,871,169 $287.87 p/Share	23,869 Reduced 32.27%	50,096 Common Stock
Jan 28 2019	BUY Exercise of conversion of derivative security	-	16,005 Added 17.79%	73,965 Common Stock
Jan 28 2019	BUY Grant, award, or other acquisition	$10,867,956 $287.87 p/Share	37,753 Added 39.44%	57,960 Common Stock
Dec 07 2018	SELL Payment of exercise price or tax liability	$121,295 $285.4 p/Share	425 Reduced 2.08%	20,039 Common Stock
Dec 07 2018	BUY Exercise of conversion of derivative security	-	425 Added 2.03%	20,464 Common Stock
Jul 30 2018	SELL Bona fide gift	-	50,000 Reduced 71.51%	19,924 Common Stock
Jul 27 2018	SELL Open market or private sale	$8,095,500 $323.82 p/Share	25,000 Reduced 26.34%	69,924 Common Stock
Feb 22 2018	SELL Payment of exercise price or tax liability	$217,725 $358.69 p/Share	607 Reduced 0.64%	93,747 Common Stock
Feb 22 2018	BUY Exercise of conversion of derivative security	-	607 Added 0.64%	94,354 Common Stock
Jan 30 2018	SELL Open market or private sale	$6,591,290 $346.91 p/Share	19,000 Reduced 16.85%	93,747 Common Stock
Jan 29 2018	SELL Payment of exercise price or tax liability	$9,896,690 $351.42 p/Share	28,162 Reduced 20.13%	111,739 Common Stock

Also insider at

JNJ

JOHNSON & JOHNSON Healthcare

Director

CVX

CHEVRON CORP Energy

Director

MAH